Compounds Useful as Inhibitors of ATR Kinase

The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this inv...

Full description

Saved in:
Bibliographic Details
Main Authors CHARRIER JEAN-DAMIEN, DAVIS CHRISTOPHER JOHN, STUDLEY JOHN, YOUNG STEPHEN CLINTON
Format Patent
LanguageEnglish
Published 11.04.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula I: wherein the variables are as defined herein. Additionally, the present invention also relates to novel processes for the production of various morpoholine based intermediates.
Bibliography:Application Number: US201213631730